Abramson Cancer Center Support Grant
艾布拉姆森癌症中心支持补助金
基本信息
- 批准号:10425591
- 负责人:
- 金额:$ 19.94万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-01 至 2022-08-31
- 项目状态:已结题
- 来源:
- 关键词:Acquired Immunodeficiency SyndromeAddressAdherenceAfrica South of the SaharaAfricanAftercareBotswanaCancer Center Support GrantCancer SurvivorCaringCessation of lifeCharacteristicsClinicClinicalConsolidated Framework for Implementation ResearchCountryDataDeveloping CountriesDiagnosisEarly DiagnosisEarly treatmentEnsureFutureGeographyGoalsGrantGynecologic OncologyHIVHIV InfectionsHospitalsIncidenceIncomeInterventionInterviewMalignant NeoplasmsMalignant neoplasm of cervix uteriMethodsMorbidity - disease rateOutcomePatient-Focused OutcomesPatientsPatternPersonsPrevalencePrivate HospitalsQuality of lifeRadiation therapyRecommendationResearchResourcesScientific Advances and AccomplishmentsShapesStructureSurveysTestingWomanWorkadvanced diseaseanticancer researchcare deliverycare outcomescohortcontextual factorscurative treatmentsdemographicsexperiencefallsimprovedinfection rateinterestlow and middle-income countriesmortalitymultidisciplinaryoutreach clinicspsychosocialresponsescreeningsurvivorshiptransportation accesstumoruptake
项目摘要
PROJECT SUMMARY
This application is being submitted in response to the Notice of Special Interest (NOSI) identified as NOT-CA-
21-058. The number of cancer survivors living in low- and middle-income countries (LMICs) is expected to grow
rapidly over the next decade driven in part by global advances in early detection and treatment, yet very little is
known about the long-term needs of cancer survivors or delivery of survivorship care in LMICs. This supplement
application will help to fill this critical research gap by quantitatively and qualitatively evaluating care outcomes
and contextual determinants of survivorship care among women diagnosed with cervical cancer in Botswana.
Cervical cancer is one of the leading cancers among women globally with 600,000 new cases and 340,000
deaths annually per 2020 estimates. Cervical cancer is an acquired immunodeficiency syndrome (AIDS)-defining
malignancy, and countries with high rates of human immunodeficiency virus (HIV) have higher incidence of
cervical cancer. Due to high HIV-infection rates and suboptimal screening uptake, most of the burden of cervical
cancer incidence, morbidity, and mortality falls on LMICs particularly in sub-Saharan Africa, with many women
presenting with advanced disease. Botswana, a sub-Saharan African country, has high rates of cervical cancer
(incidence rate of 34.4 per 100,000) and HIV (18.5% prevalence), and a high rate of mortality due to cervical
cancer (20.1 per 100,000) among women. To date, the majority of cancer research in Botswana and other LMICs
has focused on early detection or treatment, with limited research evaluating the long-term physical or
psychosocial outcomes in survivorship or how survivorship care may impact these outcomes. Furthermore, even
less is known regarding which approaches may be most impactful and sustainable to deliver survivorship care
in LMICs. As such, there is a critical need to understand the current state of survivorship in LMICs and to identify
effective strategies to ensure that all women receive optimal survivorship care. The objectives of this project are
to: 1) quantitatively describe a) patterns in post-treatment survivorship care and b) long-term physical and
psychosocial sequelae of cervical cancer using an existing cohort of patients at Princess Marina Hospital in
Gaborone, Botswana; and 2) qualitatively assess contextual determinants (e.g., quality of life, access to
resources, care delivery strategies) shaping patient experiences and adherence to survivorship care. In
combination, these data will be used to develop and/or adapt survivorship care interventions to target the specific
contextual determinants in Botswana and other LMICs. The results of this project will advance scientific
understanding of survivorship care and sequelae in LMICs and how these experiences may or may not differ
from the experiences and needs of cancer survivors in high-income countries. This project will also generate
fundamental evidence needed to improve survival and quality of life of cancer survivors globally. The long-term
goal of this project is to decrease cervical cancer mortality in Botswana and other LMICs by developing and
implementing survivorship care interventions that can be sustained in lower resource settings.
项目概要
本申请是为了响应被识别为 NOT-CA- 的特殊利益通知 (NOSI) 而提交的
21-058。生活在低收入和中等收入国家 (LMIC) 的癌症幸存者数量预计将增加
未来十年迅速发展,部分原因是早期检测和治疗方面的全球进步,但进展甚微。
了解中低收入国家癌症幸存者的长期需求或提供幸存者护理。本补充
应用程序将通过定量和定性评估护理结果来帮助填补这一关键的研究空白
以及博茨瓦纳诊断出宫颈癌的妇女生存护理的背景决定因素。
宫颈癌是全球女性的主要癌症之一,有 60 万新发病例和 34 万例
根据 2020 年估计每年死亡人数。宫颈癌是一种获得性免疫缺陷综合症(艾滋病)的定义
恶性肿瘤的发病率较高,而人类免疫缺陷病毒 (HIV) 发病率较高的国家的发病率也较高
宫颈癌。由于艾滋病毒感染率高和筛查率不高,宫颈癌的大部分负担
中低收入国家的癌症发病率、发病率和死亡率下降,特别是在撒哈拉以南非洲地区,其中许多妇女
表现为晚期疾病。博茨瓦纳是撒哈拉以南非洲国家,宫颈癌发病率很高
(发病率为每 10 万人 34.4 例)和艾滋病毒(患病率 18.5%),以及宫颈癌造成的高死亡率
女性患癌症(每 100,000 人中有 20.1 人患有癌症)。迄今为止,博茨瓦纳和其他中低收入国家的大部分癌症研究
专注于早期检测或治疗,评估长期身体或健康状况的研究有限
幸存者的心理社会结果或幸存者护理如何影响这些结果。此外,甚至
对于哪些方法对于提供幸存者护理最有影响力和可持续性,人们知之甚少
在中低收入国家。因此,迫切需要了解中低收入国家的生存现状并确定
确保所有妇女获得最佳幸存者护理的有效战略。该项目的目标是
目的:1) 定量描述 a) 治疗后生存护理的模式和 b) 长期的身体和健康状况
使用玛丽娜公主医院现有患者队列研究宫颈癌的心理社会后遗症
博茨瓦纳哈博罗内; 2) 定性评估背景决定因素(例如生活质量、获取信息的机会)
资源、护理提供策略)塑造患者体验和对生存护理的依从性。在
结合起来,这些数据将用于制定和/或调整幸存者护理干预措施,以针对具体的
博茨瓦纳和其他中低收入国家的背景决定因素。该项目的成果将推动科学发展
了解中低收入国家的幸存者护理和后遗症以及这些经历可能会或可能不会有什么不同
来自高收入国家癌症幸存者的经历和需求。该项目还将产生
提高全球癌症幸存者的生存率和生活质量需要基本证据。长期来看
该项目的目标是通过开发和降低博茨瓦纳和其他中低收入国家的宫颈癌死亡率
实施可在资源较低的环境中持续的幸存者护理干预措施。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ROBERT H VONDERHEIDE其他文献
ROBERT H VONDERHEIDE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ROBERT H VONDERHEIDE', 18)}}的其他基金
Immunotherapy and Tumor Microenvironment in HIV/AIDS Cancer Patients
HIV/艾滋病癌症患者的免疫治疗和肿瘤微环境
- 批准号:
10249752 - 财政年份:2019
- 资助金额:
$ 19.94万 - 项目类别:
non-AIDS defining cancers (NADCs) among aging HIV+ individuals
老年艾滋病毒感染者中的非艾滋病定义癌症(NADC)
- 批准号:
10249743 - 财政年份:2019
- 资助金额:
$ 19.94万 - 项目类别:
Project 1: Clinical and immune impact of radiation and dual checkpoint blockade in patients
项目 1:辐射和双重检查点封锁对患者的临床和免疫影响
- 批准号:
10005190 - 财政年份:2017
- 资助金额:
$ 19.94万 - 项目类别:
相似海外基金
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
- 批准号:
10594350 - 财政年份:2023
- 资助金额:
$ 19.94万 - 项目类别:
Evaluating Centralizing Interventions to Address Low Adherence to Lung Cancer Screening Follow-up in Decentralized Settings
评估集中干预措施,以解决分散环境中肺癌筛查随访依从性低的问题
- 批准号:
10738120 - 财政年份:2023
- 资助金额:
$ 19.94万 - 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
- 批准号:
10526768 - 财政年份:2022
- 资助金额:
$ 19.94万 - 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
- 批准号:
10701072 - 财政年份:2022
- 资助金额:
$ 19.94万 - 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
- 批准号:
10679092 - 财政年份:2021
- 资助金额:
$ 19.94万 - 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
- 批准号:
10432133 - 财政年份:2021
- 资助金额:
$ 19.94万 - 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
- 批准号:
10327065 - 财政年份:2021
- 资助金额:
$ 19.94万 - 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
- 批准号:
10377366 - 财政年份:2019
- 资助金额:
$ 19.94万 - 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
- 批准号:
10574496 - 财政年份:2019
- 资助金额:
$ 19.94万 - 项目类别:
Targeted interventions to address the multi-level effects of gender-based violence on PrEP uptake and adherence among adolescent girls and young women in Kenya
有针对性的干预措施,以解决性别暴力对肯尼亚少女和年轻妇女接受和坚持 PrEP 的多层面影响
- 批准号:
9403567 - 财政年份:2017
- 资助金额:
$ 19.94万 - 项目类别: